We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
+10.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.03B
AUM Growth
+$258M
(+15%)
Cap. Flow
+$193M
Cap. Flow
% of AUM
9.48%
Top 10 Holdings %
Top 10 Hldgs %
34.65%
Holding
2,402
New
679
Increased
420
Reduced
419
Closed
794
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$39.8M |
| 2 |
AGN
Allergan plc
AGN
|
+$27.2M |
| 3 |
BID
Sotheby's
BID
|
+$17.1M |
| 4 |
VSM
Versum Materials, Inc.
VSM
|
+$16.5M |
| 5 |
ARRY
Array Biopharma Inc
ARRY
|
+$15.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TVPT
Travelport Worldwide Limited
TVPT
|
+$27.8M |
| 2 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$19M |
| 3 |
Centene
CNC
|
+$15M |
| 4 |
LXFT
Luxoft Holding, Inc.
LXFT
|
+$14.7M |
| 5 |
NAVG
Navigators Group Inc
NAVG
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 7.64% |
| 2 | Technology | 6.61% |
| 3 | Industrials | 5.39% |
| 4 | Communication Services | 5.27% |
| 5 | Consumer Discretionary | 4.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Agnico Eagle Mines
AEM
$90.8B
| $254K | 0.01% |
+4,954
| New | +$216K |
|
652
Vanguard World Funds Extended Duration ETF
EDV
$3.26B
| $254K | 0.01% |
+2,000
| New | +$241K |
|
653
iShares Russell 1000 Growth ETF
IWF
$128B
| $251K | 0.01% |
+6,384
| New | +$247K |
|
654
PUT
Home Depot
HD
$353B
| $250K | 0.01% |
+1,200
| New | +$239K |
|
655
National Health Investors
NHI
$3.66B
| $250K | 0.01% |
3,201
+492
| +18% | +$38.2K |
|
656
NXP Semiconductors
NXPI
$60B
| $250K | 0.01% |
2,564
-13,532
| -84% | -$1.31M |
|
657
Veeva Systems
VEEV
$37.4B
| $250K | 0.01% |
1,543
+1,136
| +279% | +$166K |
|
|
LGF.A
658
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $250K | 0.01% |
20,424
+12,000
| +142% | +$173K |
|
|
ESV
659
DELISTED
Ensco Rowan plc
ESV
| $250K | 0.01% |
+29,309
| New | +$339K |
|
660
Comcast
CMCSA
$90B
| $248K | 0.01% |
+5,872
| New | +$248K |
|
661
Sinclair Inc
SBGI
$1.07B
| $248K | 0.01% |
4,622
+260
| +6% | +$13.2K |
|
662
CALL
Align Technology
ALGN
$12.1B
| $246K | 0.01% |
+900
| New | +$272K |
|
663
Boston Properties
BXP
$11.1B
| $246K | 0.01% |
1,908
-3,350
| -64% | -$450K |
|
|
FITB
664
Fifth Third Bancorp
FITB
$51.8B
| $246K | 0.01% |
8,825
-11,816
| -57% | -$324K |
|
665
Norfolk Southern
NSC
$76.1B
| $246K | 0.01% |
1,235
+1,206
| +4,159% | +$239K |
|
|
PS
666
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $245K | 0.01% |
+8,094
| New | +$260K |
|
667
Edgewell Personal Care
EPC
$1.3B
| $243K | 0.01% |
9,011
-165
| -2% | -$5.88K |
|
668
CALL
EQT Corp
EQT
$32.4B
| $243K | 0.01% |
+15,400
| New | +$295K |
|
669
Vertex Pharmaceuticals
VRTX
$124B
| $241K | 0.01% |
1,313
-3,007
| -70% | -$526K |
|
670
Franco-Nevada
FNV
$46.3B
| $240K | 0.01% |
2,829
| – | – |
|
|
CBIO
671
Crescent Biopharma
CBIO
$624M
| $239K | 0.01% |
201
+25
| +14% | +$29.9K |
|
672
Rithm Capital
RITM
$5.71B
| $239K | 0.01% |
15,500
-22,115
| -59% | -$360K |
|
673
Sprott Physical Gold and Silver Trust
CEF
$8.02B
| $237K | 0.01% |
17,877
-32,065
| -64% | -$401K |
|
674
Synopsys
SNPS
$79B
| $237K | 0.01% |
+1,844
| New | +$222K |
|
675
Herbalife
HLF
$1.26B
| $235K | 0.01% |
5,493
+4,865
| +775% | +$230K |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
MDSL
Prelude Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Prelude Capital Management held 2,402 positions worth $2.03B, up 15% from $1.77B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Prelude Capital Management deployed $193M of net new capital in Q2 2019, opening 679 new positions and adding to 420 existing holdings. Its largest new stake was Anadarko Petroleum: 593,600 shares worth $41.9M.
By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 6.7% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Red Hat Inc, an estimated $8.6M trimmed.
- Prelude Capital Management's largest Q2 2019 buy was Anadarko Petroleum: 593,600 shares worth $41.9M.
- Prelude Capital Management added most to Allergan plc in Q2 2019, an estimated $27.2M increase.
- Prelude Capital Management's biggest Q2 2019 reduction was Red Hat Inc, cutting an estimated $8.6M.
- Prelude Capital Management fully exited Travelport Worldwide Limited in Q2 2019, selling an estimated $27.8M.
- Prelude Capital Management's ten largest holdings make up 35% of its $2.03B portfolio in Q2 2019.
- Prelude Capital Management opened 679 new positions and closed 794 in Q2 2019.
- Prelude Capital Management's portfolio value rose 15% quarter-over-quarter to $2.03B.
Based on Prelude Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.